About Thymulin RX

What this site is

Thymulin RX is an independent editorial project that publishes summaries of the peer-reviewed research literature on thymulin. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The energy on these pages is deliberate — thymulin's research record genuinely reads like a series of action beats, from the zinc power-up that switches the peptide on to the single inhaled dose that reversed established asthma pathology in mice ^[7]. We lean into that to make the science readable. But the loudest panels on this site are the honest caveats, not the highlights.

What the 'RX' means here

The 'RX' in Thymulin RX is editorial framing, not a service. It signals a position the publisher takes toward the literature — reading the research with the seriousness you would want from a prescriber's reference — not a claim that this site prescribes, dispenses, compounds, or sells anything. There is no pharmacy here, no checkout, and no consultation. Thymulin is a research peptide and is not FDA-approved for any use ^[4]; nothing on this site should be read as an offer to supply it or as guidance to use it.

How we handle the evidence

Every quantitative claim on this site is tied to a numbered citation that resolves to a real study on the thymulin references page. We describe findings in the species and model where they were measured — never as human treatment, never as dosing guidance. Where the evidence is preclinical, we say so. Where the human data are sparse, dated, or based on a synthetic analog rather than native thymulin, we flag it ^[4].

We also keep thymulin separate from the peptides it is routinely confused with. Thymulin is not thymosin alpha-1, not thymosin beta-4, not thymopentin, and not thymalin — distinct molecules with their own evidence ^[4]. Getting that distinction right is part of the editorial standard here.